Sign in

CIK 0001817713 · Large accelerated filer

Janux Therapeutics, Inc.

Sign in to watch
Ticker
JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822289112
Phone
(858) 751-4493
Business address
10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  7. CERT Other Certification
  8. 8-A12B Other Registration of Securities
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. S-1/A Offering Registration Statement
  13. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  14. UPLOAD Other SEC-generated Letter
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. S-1 Offering Registration Statement
  17. UPLOAD Other SEC-generated Letter
  18. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  19. D Other Notice of Sales of Unregistered Securities
  20. DRS Other Draft Registration Statement

Page 22 of 23 · 442 filings